Recombinant Human LRRTM2 (C-6His)

Description

EnkiLife provides the Recombinant Human LRRTM2 (C-6His) protein,aslo know as Leucine-Rich Repeat Transmembrane Neuronal Protein 2,Leucine-Rich Repeat Neuronal 2 Protein,LRRTM2,KIAA0416,LRRN2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leucine-Rich Repeat Transmembrane Neuronal Protein 2 is produced by our Mammalian expression system and the target gene encoding Cys34-Arg422 is expressed with a 6His tag at the C-terminus.Accession:O43300. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:45.55 KDa. Background:Leucine-Rich Repeat Transmembrane Neuronal Protein 2 (LRRTM2) is a single-pass type I membrane protein that belongs to the LRRTM family. It contains ten LRR (leucine-rich) repeats, one LRRCT domain, and one LRRNT domain. LRRTM2 is expressed in neuronal tissues, and it interacts with DLG4 and NRXN1. LRRTM2 has been suggested to be involved in the development and maintenance of excitatory synapses in the vertebrate nervous system. LRRTM2 also regulates the surface expression of AMPA receptors. LRRTM2 acts as a ligand for the presynaptic receptors NRXN1-A and NRXN1-B.